Javier Vega-ramos
Javier Vega-ramos
Post-doctoral position at IDIBAPS
Verified email at clinic.cat
Title
Cited by
Cited by
Year
The developmental pathway for CD103+ CD8+ tissue-resident memory T cells of skin
LK Mackay, A Rahimpour, JZ Ma, N Collins, AT Stock, ML Hafon, ...
Nature immunology 14 (12), 1294-1301, 2013
7342013
Enhanced antitumor immunity in mice deficient in CD69
E Esplugues, D Sancho, J Vega-Ramos, C Martínez-A, U Syrbe, ...
The Journal of experimental medicine 197 (9), 1093-1106, 2003
1882003
DEC-205 is a cell surface receptor for CpG oligonucleotides
MH Lahoud, F Ahmet, JG Zhang, S Meuter, AN Policheni, S Kitsoulis, ...
Proceedings of the National Academy of Sciences 109 (40), 16270-16275, 2012
1392012
Induction of tumor NK-cell immunity by anti-CD69 antibody therapy
E Esplugues, J Vega-Ramos, D Cartoixà, BN Vazquez, I Salaet, P Engel, ...
Blood 105 (11), 4399-4406, 2005
732005
Criteria for dendritic cell receptor selection for efficient antibody-targeted vaccination
A Reuter, SE Panozza, C Macri, C Dumont, J Li, H Liu, E Segura, ...
The Journal of Immunology 194 (6), 2696-2705, 2015
462015
CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection
J Vega‐Ramos, E Alari‐Pahissa, J Valle, E Carrasco‐Marín, E Esplugues, ...
Immunology and cell biology 88 (7), 707-715, 2010
442010
The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells
Y Zhan, J Vega‐Ramos, EM Carrington, JA Villadangos, AM Lew, Y Xu
European journal of immunology 42 (11), 2889-2900, 2012
432012
CD69 does not affect the extent of T cell priming
E Alari-Pahissa, L Notario, E Lorente, J Vega-Ramos, A Justel, D López, ...
PLoS One 7 (10), e48593, 2012
302012
Dendritic cell migration and antigen presentation are coordinated by the opposing functions of the tetraspanins CD82 and CD37
EL Jones, JL Wee, MC Demaria, J Blakeley, PK Ho, J Vega-Ramos, ...
The Journal of Immunology 196 (3), 978-987, 2016
292016
Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets
KA Markey, M Koyama, RD Kuns, KE Lineburg, YA Wilson, SD Olver, ...
Blood 119 (24), 5918-5930, 2012
292012
Inflammation conditions mature dendritic cells to retain the capacity to present new antigens but with altered cytokine secretion function
J Vega-Ramos, A Roquilly, Y Zhan, LJ Young, JD Mintern, JA Villadangos
The Journal of Immunology 193 (8), 3851-3859, 2014
242014
Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system
Y Xu, P Lindemann, J Vega-Ramos, JG Zhang, JA Villadangos
Journal of Biological Chemistry 289 (14), 9730-9740, 2014
232014
Modulation of dendritic cell antigen presentation by pathogens, tissue damage and secondary inflammatory signals
J Vega-Ramos, A Roquilly, K Asehnoune, JA Villadangos
Current opinion in pharmacology 17, 64-70, 2014
222014
Consequences of direct and indirect activation of dendritic cells on antigen presentation: functional implications and clinical considerations
J Vega-Ramos, JA Villadangos
Molecular immunology 55 (2), 175-178, 2013
202013
Differential effect of CD69 targeting on bystander and antigen‐specific T cell proliferation
E Alari‐Pahissa, J Vega‐Ramos, JG Zhang, AR Castaño, SJ Turley, ...
Journal of leukocyte biology 92 (1), 145-158, 2012
202012
Serpinb9 (Spi6)‐deficient mice are impaired in dendritic cell‐mediated antigen cross‐presentation
A Rizzitelli, S Meuter, J Vega Ramos, CH Bird, JD Mintern, MSJ Mangan, ...
Immunology and cell biology 90 (9), 841-851, 2012
172012
Serpinb9 is a marker of antigen cross-presenting dendritic cells
MS Mangan, J Vega-Ramos, LT Joeckel, AJ Mitchell, A Rizzitelli, ...
Molecular immunology 82, 50-56, 2017
112017
578 Lauzurica P, Mueller SN, Stefanovic T, Tscharke DC, Heath WR, Inouye M, Carbone FR, 579 Gebhardt T. 2013. The developmental pathway for CD103 (+) CD8+ tissue-resident 580 …
LK Mackay, A Rahimpour, JZ Ma, N Collins, AT Stock, ML Hafon, ...
Nat Immunol 14, 1294-301, 0
6*
Shutdown of immunological priming and presentation after in vivo administration of adenovirus
RM Sutherland, SL Londrigan, JL Brady, H Azher, EM Carrington, Y Zhan, ...
Gene therapy 19 (11), 1095-1100, 2012
32012
Methods Of Treating Viral Hepatitis
F Sanchez-Madrid, CM Alonso, DS Madrid, PE Rocamora, EE Artola, ...
US Patent App. 12/944,432, 2011
12011
The system can't perform the operation now. Try again later.
Articles 1–20